MétaCan
Menu
Back to cohort
Record W4406200418 · doi:10.1002/alz.088405

Alzheimer’s disease blood tests of amyloid‐beta 42/40, %p‐tau217, 181, and 205 ratios and MTBR‐243 in real‐world populations: Results from SEABIRD and BioFINDER2

2024· article· en· W4406200418 on OpenAlexaboutno aff
Randall J. Bateman, Melody Li, Nicolas R. Barthélemy, James G. Bollinger, Yingxin He, Kanta Horie, Rama K. Koppisetti, Vitaliy Ovod, Suzanne E. Schindler, Siobhan Sutcliffe, Ganesh M. Babulal, Tammie L.S. Benzinger, Eric J. Lenze, Brian A. Gordon, Oskar Hansson, Yan Li

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldEnvironmental Science
TopicHealth, Environment, Cognitive Aging
Canadian institutionsnot available
Fundersnot available
KeywordsSeabirdDiseaseAmyloid (mycology)BETA (programming language)MedicineInternal medicineBiologyPathologyComputer scienceEcology

Abstract

fetched live from OpenAlex

Abstract Background Alzheimer’s disease (AD) blood tests that can identify and quantify amyloid plaques, tau tangles, and cognitive and clinical decline are needed in clinical practice, including primary care. However, these tests require validation in diverse groups and real‐world settings. The Study to Evaluate Amyloid in Blood and Imaging Related to Dementia (SEABIRD) enrolled 1,122 participants to determine the accuracy and validity of AD blood biomarkers, including amyloid‐β (Aβ) and phosphorylated tau (p‐tau) tests, in a diverse, community‐based sample of older adults compared with amyloid PET and cognitive and clinical measures to determine the impact of key factors (age, race, education, cognition, APOE genotype, and medical conditions). Method SEABIRD measured blood plasma Aβ42/40, %p‐tau217, %p‐tau181 and %p‐tau205 ratios by immunoprecipitation‐mass spectrometry. Measures of cognitive and clinical impairment included the AD8® dementia screen, Montreal Cognitive Assessment (MoCA), and the Clinical Dementia Rating (CDR®). 26% of participants completed amyloid PET for comparison to the blood tests. The novel plasma endogenous microtubule binding region of tau with 243 residue (E‐MTBR‐tau243) was measured in a separate cohort, the Swedish BioFINDER2 study, and compared to tau PET for tau tangle assessment. Result Of the 1,122 participants enrolled in SEABIRD, 23.5% self‐identified as Black or African American and the percentage of APOE ε4 carriers was 32.1%, as expected for a general population (Table 1). The classification accuracy (ROC AUC) of plasma measures for amyloid PET status was evaluated in a subset of participants: Aβ42/40 0.88, %p‐tau217 ratio 0.96, %p‐tau181 ratio 0.79, and %p‐tau205 ratio 0.83 (Figure 1). The classification accuracy for tau PET status was evaluated in amyloid PET positive participants in BioFINDER2: plasma E‐MTBR‐tau243 0.98, %p‐tau217 ratio 0.87, p‐tau217 concentration 0.89 (Figure 2). Conclusion In a diverse population with high comorbid disease burden, AD blood tests using ratios had similar accuracies to those reported in AD research cohorts. Our findings support the clinical use of these tests for detection of both amyloid and tau AD pathologies in the general population. Further, screening with AD blood tests can accelerate enrollment of more diverse cohorts into clinical trials, enabling treatments to demonstrate effectiveness in representative populations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.098
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.042
GPT teacher head0.293
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicHealth, Environment, Cognitive AgingFrench-language works237,207